Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.
Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check7 days agoChange DetectedNew study records have been added, including three sites in Boston and Tokyo, while previous records and a notice about display delays have been removed.SummaryDifference2%
- Check14 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.5%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check36 days agoChange DetectedA new study has been added with 152 Tokyo locations, including a specific site in Shibuya-ku, while a previous study with 151 locations and FDA safety alerts has been removed.SummaryDifference0.7%
- Check43 days agoChange DetectedThe study count has increased to 151 with a new location added in Toyoake, Aichi, Japan, while the previous study count of 150 has been removed.SummaryDifference0.8%
- Check50 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.